Although more common among the COVID-19 decedents with cardiac microthrombi, outpatient use of ACE inhibitor/ARB was not independently associated with cardiac microthrombi after multivariable adjustment (Table 1 and Supplemental Figure 1). The gene discussed is ACE; the disease is COVID-19.